ZDHJERK
New to Zerodha? Sign-up for free.
New to Zerodha? Sign-up for free.
-
Share Price
-
Financials
-
Revenue mix
-
Shareholdings
-
Peers
-
Forensics
- 5D
- 1M
- 6M
- YTD
- 1Y
- 5Y
- MAX
This data is currently unavailable for this company.
-
Summary
-
Profit & Loss
-
Balance sheet
-
Cashflow
| (In Cr.) |
|---|
| (In Cr.) | ||||
|---|---|---|---|---|
|
This data is currently unavailable for this company. |
| (In %) |
|---|
| (In Cr.) |
|---|
| Financial Year (In Cr.) |
|---|
-
Product wise
-
Location wise
Revenue Mix
This data is currently unavailable for this company.
Revenue Mix
This data is currently unavailable for this company.
Recent events
-
News
-
Corporate Actions
This data is currently unavailable for this company.
Events:
More Nano Cap Ideas
See similar 'Nano' cap companies with recent activity
Promoter Buying
Companies where the promoters are bullish
Capex
Companies investing on expansion
Superstar Investor
Companies where well known investors have invested
Popular questions
-
Business
-
Financials
-
Share Price
-
Shareholdings
What does DhanvantriJeevan Rek do?
Dhanvantri Jeevan Rekha Ltd is a multi speciality hospital providing a wide range of medical services including Cardiac Care, Neuro Surgery, Orthopedic Surgery, Urology, and other specialized treatments.
Who are the competitors of DhanvantriJeevan Rek?
DhanvantriJeevan Rek major competitors are Clinitech Laboratory, Gian Life Care, Dr Lalchandani Labs, Broach Lifecare Hosp, Looks Health Service, Dolphin Medical Serv, Family Care Hospital. Market Cap of DhanvantriJeevan Rek is ₹10 Crs. While the median market cap of its peers are ₹8 Crs.
Is DhanvantriJeevan Rek financially stable compared to its competitors?
DhanvantriJeevan Rek seems to be less financially stable compared to its competitors. Altman Z score of DhanvantriJeevan Rek is 3.53 and is ranked 4 out of its 8 competitors.
Does DhanvantriJeevan Rek pay decent dividends?
The company seems to be paying a very low dividend. Investors need to see where the company is allocating its profits. DhanvantriJeevan Rek latest dividend payout ratio is 0% and 3yr average dividend payout ratio is 0%
How has DhanvantriJeevan Rek allocated its funds?
Companies resources are majorly tied in miscellaneous assets
How strong is DhanvantriJeevan Rek balance sheet?
Balance sheet of DhanvantriJeevan Rek is strong. It shouldn't have solvency or liquidity issues.
Is the profitablity of DhanvantriJeevan Rek improving?
Yes, profit is increasing. The profit of DhanvantriJeevan Rek is ₹0.66 Crs for Mar 2025, ₹0.17 Crs for Mar 2024 and -₹0.22 Crs for Mar 2023
Is the debt of DhanvantriJeevan Rek increasing or decreasing?
Yes, The net debt of DhanvantriJeevan Rek is increasing. Latest net debt of DhanvantriJeevan Rek is -₹1.14 Crs as of Sep-25. This is greater than Mar-25 when it was -₹5.04 Crs.
Is DhanvantriJeevan Rek stock expensive?
Yes, DhanvantriJeevan Rek is expensive. Latest PE of DhanvantriJeevan Rek is 104, while 3 year average PE is 14.54. Also latest EV/EBITDA of DhanvantriJeevan Rek is 29.53 while 3yr average is 6.96.
Has the share price of DhanvantriJeevan Rek grown faster than its competition?
DhanvantriJeevan Rek has given better returns compared to its competitors. DhanvantriJeevan Rek has grown at ~15.26% over the last 1yrs while peers have grown at a median rate of -39.77%
Is the promoter bullish about DhanvantriJeevan Rek?
Promoters stake in the company seems stable, and we need to go through filings and allocation of resources to gauge promoter bullishness. Latest quarter promoter holding in DhanvantriJeevan Rek is 19.65% and last quarter promoter holding is 19.65%.
Are mutual funds buying/selling DhanvantriJeevan Rek?
There is Insufficient data to gauge this.
